NCT03444298View on ClinicalTrials.gov

A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

March 2, 2023

Study Completion Date

March 6, 2023

Conditions

Airway InflammationAsthma

Interventions

DRUG

Gamma Tocopherol

Each dose consists of two (700 mg) capsules by mouth once daily for a total of 7 days.

DRUG

Placebo

Each dose consists of two capsules by mouth once daily for a total of 7 days.

Trial Locations (1)

27599

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill

All Listed Sponsors

collaborator

National Institute of Environmental Health Sciences (NIEHS)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT03444298 - A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults | Biotech Hunter | Biotech Hunter